DrugPatentWatch Archives

You are currently viewing the 2010 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: promethazine hydrochloride

Summary for Generic Name: promethazine hydrochloride

Drug Master File Entries: see list12
Therapeutic Class:Antiemetics
Respiratory Tract Agents

Clinical Trials for: promethazine hydrochloride

Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial
Status: Completed Condition: Migraine Headaches; Nausea; Restlessness

Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine
Status: Recruiting Condition: Drug Metabolism, Poor, CYP2D6-RELATED

Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis
Status: Completed Condition: Aphthous Stomatitis

Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine
Status: Completed Condition: Sleep

Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
Status: Completed Condition: Focus of Study: Absorption of the Three Components in the Topical ABH Gel in Healthy Volunteers, and Determine if There Are Any Adverse Effects.

Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Patients With Nausea
Status: Active, not recruiting Condition: Nausea and Vomiting

A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery
Status: Completed Condition: Surgery; Pain

To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
Status: Completed Condition: Nasal Congestion

Diphenhydramine for Acute Migraine
Status: Recruiting Condition: Migraine

Study of Promethazine for Treatment of Diabetic Gastroparesis
Status: Not yet recruiting Condition: Diabetic Gastroparesis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
promethazine hydrochloride
INJECTABLE; INJECTION008857Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
promethazine hydrochloride
INJECTABLE; INJECTION084223Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
promethazine hydrochloride
INJECTABLE; INJECTION084222Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
promethazine hydrochloride
INJECTABLE; INJECTION083955Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology